2020 · Paper V · 10 marksFrequently asked

The 2020 Nobel Prize for Physiology and Medicine was awarded to three scientists for their work on HCV. What do you know about this virus and the disease it causes? Is there any vaccine available for this disease?

In short

Hepatitis C virus is an enveloped, positive-sense RNA virus of the Flaviviridae family, spread mainly through blood, that causes silent chronic hepatitis progressing to cirrhosis and liver cancer. No vaccine exists, but oral direct-acting antivirals cure more than 95 percent of patients in 12 weeks.

Model answer

Ghissu Editorial · Verified 4 Oct 2026

Introduction
The 2020 Nobel Prize recognized the discovery of Hepatitis C virus (HCV), crucial for understanding chronic liver diseases like cirrhosis and liver cancer globally. This breakthrough has enabled targeted diagnosis, treatment, and prevention strategies, significantly impacting public health.
Institutional Framework and Research Capacity
•

National and State Coordination

ICMR leads hepatitis research nationally, with regional centres like ICMR-National Institute of Virology Pune supporting Andhra Pradesh’s surveillance, diagnostics, and epidemiological studies to monitor HCV prevalence.

•

Health Infrastructure Support

Schemes such as Pradhan Mantri - Ayushman Bharat Health Infrastructure Mission1 (PM-ABHIM) bolster state capacity for hepatitis diagnosis and treatment. Andhra Pradesh’s government hospitals and medical colleges provide access to direct-acting antivirals (DAAs), which have revolutionized HCV therapy with high cure rates.

Implementation Challenges and Disease Impact
•

Economic Barriers and No Vaccine

Despite reduced DAA costs due to generic production in India, affordability remains a challenge in rural and tribal areas. No vaccine exists for HCV, unlike hepatitis A and B, complicating prevention efforts and making safe blood transfusion and harm reduction strategies essential.

Way Forward
•

Expand Screening and Treatment

Leveraging National AIDS Control Programme2’s outreach experience and ensuring subsidized DAAs through Ayushman Bharat can enhance early diagnosis and treatment access, reducing disease burden.

Conclusion
The Nobel-winning discovery of HCV has advanced treatment options, but the absence of a vaccine demands robust screening, treatment, and awareness programs in Andhra Pradesh to achieve the 2030 Sustainable Development Goal of ending viral hepatitis as a public health threat. This aligns with the vision of "Sabka Saath Sabka Vikas" for inclusive health development.

This model answer is indicative and the model can make mistakes; please verify key facts independently.

Hand-drawn diagram: Course of Hepatitis C. Course of Hepatitis C. Flow: Infection through blood, needles → Silent chronic hepatitis → Cirrhosis of the liver → Hepatocellular carcinoma
Diagram: Course of Hepatitis C

Practise this question

  1. 1Get the answer sheet

    Sized for this question.

  2. 2Write your answer

    Timed, by hand.

  3. 3Get it marked

    Your score and what to fix.

Share this questionWhatsAppTelegramXLinkedIn

This chapter in the exam

Human diseases; genetic engineering basics; biotechnology in agriculture; vaccines54 questions

Asked in 8 of 8 sittings since 2008

2008
5
2011
6
2012
15
2016
11
2017
4
2020
5
2023
3
2025
5

Most tested: Vaccines and immunisation, alongside GM crops/biotech agriculture.

All 54 questions, sorted by sub-topic, with model answers and practice.

Question from the official APPSC Group-I Mains 2020 paper. Answer written by Ghissu's engine and checked against our editorial standards. Found an error? Tell us and we correct it within 48 hours.

Ghissu

OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·
OUTWORK·
OUTTHINK·
MASTER THE SYSTEM·